NCT02992938View on ClinicalTrials.gov

Administration of Acetazolamide to Prevent Remifentanil Induced Hyperalgesia

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

September 28, 2018

Study Completion Date

September 28, 2018

Conditions
HyperalgesiaOpioid-Related Disorders
Interventions
DRUG

Acetazolamide

DRUG

Placebo Oral Tablet

Trial Locations (1)

7563215

Faculty of Medicine, University of Chile, Santiago

All Listed Sponsors
lead

University of Chile

OTHER

NCT02992938 - Administration of Acetazolamide to Prevent Remifentanil Induced Hyperalgesia | Biotech Hunter | Biotech Hunter